Department of Cardiothoracic Surgery, The Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia.
Department of Cardiothoracic Surgery, The Royal Children's Hospital, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia.
J Thorac Cardiovasc Surg. 2017 Dec;154(6):2019-2027. doi: 10.1016/j.jtcvs.2017.06.042. Epub 2017 Jun 28.
Atrioventricular valve regurgitation is a significant cause of morbidity and mortality in patients with unbalanced atrioventricular septal defect. However, knowledge of the outcomes of atrioventricular valve repair in children with unbalanced atrioventricular septal defect and univentricular physiology is limited.
We conducted a retrospective review of all patients with unbalanced atrioventricular septal defect treated with single-ventricle palliation who underwent atrioventricular valve surgery at The Royal Children's Hospital.
Between 1976 and 2016, 139 children with unbalanced atrioventricular septal defect underwent single-ventricle palliation, of whom 31.7% (44/139) required atrioventricular valve surgery. Repair of the atrioventricular valve was attempted in 97.7% (43/44) of patients, of whom 4.7% (2/43) were converted to replacement during the initial operation. Replacement of the atrioventricular valve without attempted repair was performed in 2.3% (1/44) of patients. Early mortality was 18.2% (8/44). Freedom from death or transplantation at 10 years was 66.0% (95% confidence interval, 49.1-78.5) and at 20 years was 53.3% (95% confidence interval, 32.1-70.6). In multivariable analysis, significant predischarge atrioventricular valve regurgitation (hazard ratio, 6.4; P = .002), age less than 1 year (hazard ratio, 8.3; P = .01), and repair before stage II palliation (hazard ratio, 3.4; P = .04) were associated with death. Freedom from reoperation at 10 years was 61.9% (95% confidence interval, 41.9-76.8) and at 20 years was 56.3% (95% confidence interval, 35.3-72.8). Moderate or greater atrioventricular valve regurgitation at discharge was associated with an increased risk of reoperation (hazard ratio, 1.8; P = .03). Of transplant-free survivors, atrioventricular valve regurgitation was less than moderate in 60.0% (15/25) at the most recent follow-up.
Atrioventricular valve surgery in patients with unbalanced atrioventricular septal defect is associated with substantial mortality and a high rate of reoperation. Successful atrioventricular valve repair is associated with better survival and freedom from reoperation.
房室瓣反流是不平衡房室间隔缺损患者发病率和死亡率的重要原因。然而,对于单心室修复的不平衡房室间隔缺损患儿的房室瓣修复的结果,我们知之甚少。
我们对在皇家儿童医院接受单心室姑息治疗并接受房室瓣手术的所有不平衡房室间隔缺损患者进行了回顾性研究。
1976 年至 2016 年期间,139 例不平衡房室间隔缺损患者接受了单心室姑息治疗,其中 31.7%(44/139)需要房室瓣手术。97.7%(43/44)的患者尝试修复房室瓣,其中 4.7%(2/43)在初次手术中转为置换。2.3%(1/44)的患者行房室瓣置换而未尝试修复。早期死亡率为 18.2%(8/44)。10 年时无死亡或移植生存率为 66.0%(95%置信区间,49.1-78.5),20 年时为 53.3%(95%置信区间,32.1-70.6)。多变量分析显示,显著的出院前房室瓣反流(危险比,6.4;P=0.002)、年龄小于 1 岁(危险比,8.3;P=0.01)和在二期姑息治疗前修复(危险比,3.4;P=0.04)与死亡相关。10 年时无再手术生存率为 61.9%(95%置信区间,41.9-76.8),20 年时为 56.3%(95%置信区间,35.3-72.8)。出院时中度或以上房室瓣反流与再手术风险增加相关(危险比,1.8;P=0.03)。在无移植幸存者中,25 例中有 60.0%(15 例)在最近一次随访时房室瓣反流小于中度。
不平衡房室间隔缺损患者的房室瓣手术死亡率高,再手术率高。成功的房室瓣修复与更好的生存率和无再手术率相关。